| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 05/15/1991 | CN1051389A Novel antibodies reactive with human carcinomas |
| 05/14/1991 | WO1991007418A1 Chimeric mouse-human a10 antibody with specificity to a human tumor cell antigen |
| 05/14/1991 | US5015755 9-anthrylalkyl compounds |
| 05/14/1991 | US5015463 Porphyrins for fluorescent detection of tumor cells |
| 05/14/1991 | CA2044590A1 Chimeric mouse-human a10 antibody with specificity to a human tumor cell antigen |
| 05/08/1991 | EP0426610A2 Nonionic X-ray contrast agent with high iodine content |
| 05/08/1991 | EP0425537A1 Method for myocardial infarct risk assessment. |
| 05/07/1991 | US5013865 X-ray contrast media, controlled stoichiometry and kinetics |
| 05/07/1991 | US5013556 Lipids derivatized with polyoxyethylene glycol, drug delivery, antitumor agents |
| 05/04/1991 | CA2331088A1 Urinary tumor associated antigen, antigenic subunits uses and methods of detection |
| 05/04/1991 | CA2029194A1 Nonionic x-ray contrast medium with high iodine content |
| 05/02/1991 | WO1991005807A1 Organic magnetic composite |
| 05/02/1991 | WO1991005599A1 Process for making aqueous dispersions |
| 05/02/1991 | WO1991005559A1 Diagnosis and treatment of neuro-cognitive disorders associated with systemic immunological malfunction |
| 05/02/1991 | EP0425154A1 Sustained release elements |
| 05/02/1991 | EP0203962B1 Diamide-dtpa-paramagnetic contrast agents for mr imaging, apparatus and methods |
| 05/01/1991 | CA2028605A1 Chemiluminescence assay of in vivo inflammation |
| 04/30/1991 | US5011925 Complexing agents for nuclear magnetic resonance imaging in medical diagnosis |
| 04/30/1991 | US5011677 For radiation therapy |
| 04/25/1991 | DE3935257A1 Liposome(s) contg. fluorescent marker and coupled to antibody - useful as diagnostic reagent and for targetted delivery of therapeutic agent for treating cancer, malaria etc. |
| 04/24/1991 | WO1991005762A1 Multi-site metal chelating agents |
| 04/24/1991 | EP0424311A1 Paramagnetic oil emulsion as MRI contrast agents |
| 04/24/1991 | EP0381742A4 Receptor mediated endocytosis type mri contrast agents |
| 04/24/1991 | CA2069886A1 Multi-site metal chelating agents |
| 04/24/1991 | CA2027865A1 Sustained release elements |
| 04/23/1991 | US5010191 Imaging agents for in vivo magnetic resonance and scintigraphic imaging |
| 04/21/1991 | WO1991005546A1 Solid tumor treatment method and composition |
| 04/21/1991 | WO1991005545A1 Liposome microreservoir composition and method |
| 04/20/1991 | CA2026545A1 Paramagnetic oil emulsiions as mri contrast agents |
| 04/18/1991 | WO1991004664A1 Fluorocarbon emulsions containing amino acid based anti-inflammatory agents and buffer systems |
| 04/18/1991 | WO1990015076A3 MONOCLONAL ANTIBODIES AGAINST LEUKOCYTE ADHESION RECEPTOR β-CHAIN, METHODS OF PRODUCING THESE ANTIBODIES AND USE THEREFORE |
| 04/18/1991 | DE3933850A1 Zytolyse-inhibitor (zli), eine diese blutplasmaprotein kodierende dna-sequenz, sowie ein plasmid, ein wirtsorganismus und ein verfahren zur gewinnung dieses proteins Cytolysis inhibitor (ZLI), these a blood plasma protein encoding DNA sequence, and a plasmid, a host organism and a method for obtaining this protein |
| 04/18/1991 | CA2066046A1 Fluorocarbon emulsions containing amino acid based anti-inflammatory agents and buffer systems |
| 04/17/1991 | EP0422021A1 Magnetic particle-containing compositions |
| 04/17/1991 | EP0416033A4 Macrocyclic chelates and methods of use thereof |
| 04/14/1991 | CA2027527A1 Process for the preparation of aqueous dispersions |
| 04/10/1991 | EP0421838A1 Method of making dental plaque observable |
| 04/10/1991 | EP0421697A2 Contrast agents and methods for enhancing magnetic resonance imaging |
| 04/09/1991 | US5006663 Antitumor agents |
| 04/09/1991 | US5006643 Process for preparing isothiocyanato functionalized metal complexes |
| 04/07/1991 | WO1991005043A1 Cytolysis inhibitor proteins (cli) and dna sequences coding for said proteins |
| 04/07/1991 | CA2042605A1 Cytolysis inhibitor proteins (cli), dna sequences coding for said proteins, and plasmids, host organisms, and processes for obtaining said proteins |
| 04/04/1991 | WO1991004272A1 Recombinant polypeptides and peptides, nucleic acids coding for the same and use of these polypeptides and peptides in the diagnostic of tuberculosis |
| 04/04/1991 | WO1991000289A3 Targeted liposomes and methods for liposome-protein coupling |
| 04/03/1991 | EP0146583B1 Radiopaque medium |
| 04/02/1991 | US5004835 For x-ray imaging |
| 04/02/1991 | US5004811 Tetrapyrrole aminocarboxylic acids |
| 04/02/1991 | US5004697 Cationized antibodies for delivery through the blood-brain barrier |
| 04/02/1991 | CA1282405C Method for making uniformly sized particles from water-insoluble organic compounds |
| 04/02/1991 | CA1282330C Drug depot containing cytostatics |
| 03/28/1991 | DE3931005A1 Ultrasound transmission medium - made by combining cold aq. soln. of potato starch and salt to hot aq. soln. of citric acid |
| 03/28/1991 | CA2026292A1 Plaque disclosing compositions |
| 03/27/1991 | EP0418335A1 Process for the determination, by means of free radicals, of the anti-oxidant properties of a living organism or a potentially agressive agent. |
| 03/26/1991 | US5002753 Z Isomers, Halovinyl Substituents |
| 03/26/1991 | CA1282069C Antibody complexes of hapten-modified diagnostic or therapeutic agents |
| 03/21/1991 | WO1991003737A1 Means for diagnosing demyelinating neuropathies, in particular multiple sclerosis |
| 03/21/1991 | WO1991003556A1 Recombinant product |
| 03/20/1991 | EP0417927A1 Detection and treatment of infections with immunoconjugates |
| 03/20/1991 | EP0417271A1 Diagnosis and treatment of insulin dependent diabetes mellitus |
| 03/13/1991 | EP0416984A1 Means for the diagnosis of neurological demyelinisation disorders, especially multiple sclerosis |
| 03/13/1991 | EP0416698A1 Contrast media |
| 03/13/1991 | EP0416033A1 Macrocyclic chelates and methods of use thereof. |
| 03/13/1991 | EP0397595A3 A method for the evaluation of antiallergic substances |
| 03/12/1991 | US4999445 N-Carboxylated Desferrioxamine B Complexes with Metal Ions |
| 03/12/1991 | US4999188 Methods for embolization of blood vessels |
| 03/12/1991 | CA1281284C Mucosal allergo-test and relevant device for the determination of specific and total ige |
| 03/09/1991 | WO1991003489A1 Structural alterations of the egf receptor gene in human gliomas |
| 03/07/1991 | WO1991002541A1 Detection and treatment of infections with immunoconjugates |
| 03/07/1991 | CA2024731A1 Means for the diagnosis of demyelinating neuropathy and specially multiple sclerosis |
| 03/06/1991 | WO1991003261A1 Novel magnetic resonance imaging agents |
| 03/06/1991 | EP0414806A1 High ratio active agent:lipid complex. |
| 03/06/1991 | EP0414700A1 Contrast agents for magnetic resonance imaging. |
| 03/06/1991 | CA2065415A1 Magnetic resonance imaging agents |
| 03/05/1991 | WO1991003263A1 Contrast media |
| 03/05/1991 | US4997639 Method for detecting cholesterol deposited in bodies of mammals |
| 03/05/1991 | US4997454 Precipitation |
| 03/05/1991 | CA2064880A1 Contrast media |
| 03/01/1991 | WO1991003262A1 New cores for technetium radiopharmaceuticals |
| 03/01/1991 | WO1991003200A1 Hydroxy-aryl metal chelates for diagnostic nmr imaging |
| 03/01/1991 | CA2039732A1 Cores for technetium radiopharmaceuticals |
| 02/27/1991 | EP0414288A1 Contrast media |
| 02/27/1991 | EP0414287A1 Particulate contrast media |
| 02/27/1991 | EP0413766A1 Synthetic peptides for arterial imaging |
| 02/27/1991 | EP0177545B1 Use of ferromagnetic particles in contrast agents for nmr imaging and contrast agents |
| 02/26/1991 | US4996041 Administering complex of isotope and liquid carrier to measure the production of water |
| 02/23/1991 | WO1991002811A1 Resuspendable coated magnetic particles and stable magnetic particle suspensions |
| 02/21/1991 | WO1991002252A1 Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof |
| 02/21/1991 | WO1991002063A1 Improvements in granulocyte-macrophage colony-stimulating factor receptor and derivatives thereof |
| 02/21/1991 | WO1991002062A2 C-erbb-2 external domain: gp75 |
| 02/21/1991 | WO1991001754A1 Direct radiolabeling of antibodies and other proteins with technetium or rhenium |
| 02/21/1991 | WO1991001727A2 Method of detection and treatment of malignant and non-malignant lesions by photochemotherapy |
| 02/21/1991 | WO1990011523A3 Catalyzed reporter deposition |
| 02/21/1991 | CA2060663A1 Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof |
| 02/20/1991 | EP0413405A2 Use of amide complex compounds |
| 02/19/1991 | WO1991002546A1 A reagent for the detection of fibrinolytic activity |
| 02/19/1991 | US4994560 Functionalized polyamine chelants and radioactive rhodium complexes thereof for conjugation to antibodies |
| 02/19/1991 | US4994259 Nuclear magnetic imaging contrast agents; stability |
| 02/19/1991 | US4993415 Emulsion mixtures comprising a perfluorocarbon bromide; contrast agent |
| 02/19/1991 | CA2065147A1 Reagent for the detection of fibrinolytic activity |
| 02/19/1991 | CA1280367C Pharmaceutical composition of the type which undergoes liquid-gel phase transition |